Tuesday, November 17, 2026

Daiichi Sankyo Healthcare Launches Co-Creation Program! Creating new value in the two areas of "women's health" and "sleep

As the world of healthcare is entering an era of change, Daiichi Sankyo Healthcare hosts an accelerator program!
We invite startups to submit co-creation ideas in the two areas of "women's health" and "sleep" and take on the challenge of creating new value. The deadline for applications is June 30.

What is the background of the co-creation program?

The development of an aging society with a very low birthrate and rapid advances in technology, including AI and IoT. These two major waves are ushering in an era of change in the world of healthcare. For example, the evolution from care for an unspecified group of people to personalized care for each individual. The shift to total care that not only treats illness, but also takes prevention and prognosis into consideration. New solutions based on new ideas are now required to strongly support the quality of life of all people, from children to seniors, who will live for 100 years in this era.

Daiichi Sankyo Healthcare has created numerous products and brands that benefit people's health and beauty. In this matching program, we are taking on the challenge of creating new value through co-creation, particularly in the two areas of "women's health" and "sleep. We are looking forward to receiving entries from startups who have new technologies, know-how, and ideas, and who are willing to take on the challenge of working together toward this goal.

Daiichi Sankyo Healthcare Startup Co-Creation Program

▶︎ Application deadline: Wednesday, June 30, 20:00
▶︎ Target companies: all domestic and international startups. Any industry.
▶︎ Participation fee: Free
▶︎ Sponsored by Daiichi Sankyo Healthcare Co.

What we want to achieve with the Co-Creation Program

1. We want to support women to "be more energetic and be themselves". (Femtec)

Solving women's health issues has always been an important theme for us, as evidenced by our Loxonin S products, which alleviate menstrual pain, and Minon skin care products for sensitive and dry skin. Going forward, we will take this initiative even further forward. Focusing on issues at each stage of life, from puberty to maturity to menopause, we will proactively incorporate cutting-edge technologies to provide total care that supports women's "healthy and personal lives.

<Main issues to be resolved
Menstrual issues: Menstrual cramps, PMS (premenstrual syndrome), irregular periods, etc.
Menopausal issues: Physical symptoms such as hot flashes and hot flashes, mental symptoms such as irritability and anxiety.
Issues related to infertility and pregnancy: Fertility support, fertility testing, pregnancy care, etc.
Other issues: Delicate zone care, various testing services (breast cancer, cervical cancer, etc.), etc.


New functional materials (food, cosmetics, etc.), measurement and diagnostic devices, health management applications, support devices and equipment, online consultation, BtoB business, digital communication, etc.

2. We want to achieve "the best sleep" by integrating a variety of approaches. (Sleep)

Sleep, along with diet and exercise, is the basis of health promotion and is deeply related to the prevention of lifestyle-related diseases and mental health. As a pharmaceutical company, we are strengthening our efforts in this area by holding an "annual sleep assessment campaign" for companies, developing functional food products, and conducting joint research with universities. By combining the knowledge and networks we have cultivated with your technologies and ideas, we hope to achieve "the best sleep for each and every one of us" and furthermore, to "energize society as a whole through sleep.

<Main issues to be addressed
Further improvement of sleep quality (especially improvement in falling asleep, waking up in the middle of the night, and feeling lethargic after waking up from sleep)
Improvement of skin condition, performance, and prevention of lifestyle-related diseases through sleep.
Propose new lifestyles such as power naps (active napping)

<Technologies and know-how you wish to collaborate with
Measuring and diagnostic devices, management apps
New functional materials and technologies (food, cosmetics, etc.)
Solutions for quality sleep (bedding, appliances, clothing, sports, music, bathing, fragrances, etc.)
Games and entertainment related to sleep
Collaboration in R&D (data acquisition, analysis, etc.)
Collaboration in business models (BtoB business, subscription models, etc.)

Daiichi Sankyo Healthcare's management resources that can be utilized by startups (resources)

Products that support health and beauty

OTC drugs such as the antipyretic analgesic "Loxonin S" and the general cold remedy "Lulu", functional skincare products such as "Minon", "Transino", "Riceforce" and "Bright Age", functional oral care products such as "Clean Dental" and "Breath Labo", quasi-drugs such as "Regaine", and foods with functional claims are currently our main products. Quasi-drugs and functional food products such as "Regaine" are currently our main products. We can utilize these brands across a wide range of categories and the knowledge (formulation technology, marketing know-how, etc.) we have cultivated in each category for co-creation with our customers.

Sales network to pharmacies, drugstores and convenience stores

We have business with more than 56,000 pharmacies and drugstores nationwide and sell our products through convenience store companies. These sales channels and the strong relationships of trust we have built with retailers can be utilized for co-creation with our customers.

In-house mail-order customer base and web marketing capabilities

Our subsidiary, IM, sells skincare products, pharmaceuticals, and functional foods through its own mail-order business. We can utilize our active membership list of several million members and our web marketing know-how, which we have refined to acquire new customers and improve retention rates, for co-creation with you.

Pharmaceutical Company R&D Capability to Generate Added Value

We are thoroughly committed to "scientific evidence," "customer satisfaction," and "continuous creation of new added value," and are engaged in formulation research and basic research of OTC drugs and skincare products at our research center in Shinagawa. We can utilize these research and development systems for co-creation with you.

The Daiichi Sankyo Group's collective strengths

As a group company of Daiichi Sankyo, a global pharmaceutical company, we have been engaged in various activities such as the switch-OTC of prescription drugs and the promotion of skin care during cancer treatment in collaboration with both companies. We can utilize the comprehensive strength of the group and its potential for development with a view to healthcare as a whole in our co-creation with you.

Cross-industry networking for health and wellness

We are working to solve social issues through active alliances with companies in different industries and business categories, such as the "Annual Sleep Assessment Campaign" that we are promoting under a consortium with an insurance company, an IT company, and others. We can utilize the foundation of this cross-industry network, which allows us to leverage each other's strengths, for co-creation with you.

Ability to disseminate information through owned media

The company has developed a variety of owned media, including "Kenko Bijuku," a website that provides useful information for daily life, "Drugs and Health Information Bureau," and "Nekoichi-san," a self-care awareness YouTube channel. The corporate website itself has earned a high level of customer loyalty, with 50 million visitors a year and ranking in the top five for "intention to recommend products and services after accessing" in the Web Equity2021 survey, which calculates website value rankings*. We can utilize these information media and consumer contacts for co-creation with you.

*In the Web Equity2021 survey conducted by Tribeca, our website was ranked in the top 5 in the "likeliest to recommend a product or service to others after purchasing or using it" category, following Tokyo Disneyland, Starbucks, USJ, and others, and was evaluated as providing useful and attractive information, leading to high loyalty. The site was evaluated as providing useful and attractive information, leading to a high level of loyalty.
*Reference WebEquity2021 Website Value Ranking Results Report [Part 3
https://brand.tribeck.jp/video_webinar/we/

Funds

If we can envision a more concrete collaboration plan, we will consider investing in the company.

Enthusiasm for the Program

We believe that startups have the spirit to pioneer a new era, and have technologies and ideas that cannot be imitated by others. We have the experience and marketing know-how in the fields of pharmaceuticals, skin care, oral care, and functional foods. Let's pool our resources to the fullest and envision an exciting future for healthcare together. Our goal is to co-create a long-term vision of mutual growth. We look forward to receiving your passionate and innovative proposals.

[Recruitment]Join Daiichi Sankyo Healthcare and create new value in the "healthcare" field.

September 1, 2022
PORT Editorial Officehttps://port.creww.me/
PORT by Creww is an open innovation media for startups, entrepreneurs, entrepreneurs in recovery, and companies seeking to create new businesses on the theme of social issues, operated by Creww Co.
- Advertisment -
- Advertisment -

Featured

東芝のオープンイノベーション、協業検討に進む2社が決定 ダイナミックマッププラットフォームとArithmerを選定

ReGACY Innovation Group株式会社(東京都千代田区)は、企画・運営パートナーとして支援する株式会社東芝の「Toshiba OPEN INNOVATION PROGRAM 2026」で、協業検討に進む参加企業2社が決定したと発表した。7月に募集した共創プランの中から、ダイナミックマッププラットフォーム株式会社とArithmer株式会社を選定。両社は東芝グループの「Hybrid-3D LiDAR」と「気象データサービス」を活用し、物流・インフラ分野などでの新たなソリューション共創を目指す。12月中旬の成果発表会に向け、実証と事業性検証を進める。 本プログラムでは、2026年7月6日から7月26日まで参加企業を募集しており、応募のあった共創プランの中から、ダイナミックマッププラットフォーム株式会社、Arithmer株式会社の2社が選定されました。 両社は、東芝グループが保有する「Hybrid-3D LiDAR」および「気象データサービス」の技術・データを用いて、物流・インフラ分野やデータ活用領域における新たなビジネスソリューションの共創を目指します。 今後は、12月中旬に予定されている成果発表会に向けて実証や事業性検証を進めるとともに、事業化を見据えた協業の検討を加速していきます。

新潟日報社、オープンイノベーションプログラム2026ピッチ審査会で「三ツ目」「想ひ人」2社を選定

新潟日報社は8月4日、「新潟日報社 オープンイノベーションプログラム2026 ピッチ審査会」を開催した。Creww株式会社が提供する「Creww Growth」を活用し、5月15日から6月15日にかけて新潟県や社会が抱える課題解決に向けた協業アイデアを募集。応募61件の中から書類審査を通過した8社がピッチに参加し、審査の結果「三ツ目」(新潟県三条市)と「想ひ人」(東京都)の2社を選定した。今後は実証事業等を通じて事業化を進める予定。

【ヤマサキ × BeeInventor】高温下での過酷な作業環境から、データは命を守れるか——創業151年の工業炉建設会社とスマートヘルメット新興企業が挑む「熱中症ゼロ」の現場

明治8年創業の株式会社ヤマサキは、建設業界向けアクセラレータープログラム「ヤマサキ×オープンイノベーションプログラム2024」を通じて、スマートヘルメットを手がけるビーインベンターとのPoCを実施した。内部温度800度を超える製鉄炉の傍らで働く現場作業員の熱中症リスクをAIで早期検知するという挑戦は、今まさに第2フェーズへと移行しようとしている。プロジェクトリーダーの向井裕一氏と、BeeInventor(ビーインベンター)のNao SeoChon氏に話を伺った。

【ヤマサキ × CHAOSRU】「誰も知らない技術」を、誰もが体験できる価値へ——創業151年の工業炉建設会社とVRスタートアップが挑む、採用×認知の壁の壊し方

明治8年創業の株式会社ヤマサキは、製鉄に欠かせない築炉の技術を持ちながら、業界・企業の認知度の壁が採用の課題となっていた。この課題の突破口を探るべく参加したのが、『ヤマサキ×オープンイノベーションプログラム2024』だ。プログラムを通じて、VR・XR技術を核とする株式会社CHAOSRUとの協業をスタート。2025年7月から始まったPoC(実証実験)では、高校生向け採用説明会へのVR体験の導入により、ブース来訪者数に明らかな変化が生まれている。アクセラレータープログラムを通じたスタートアップとの協業で何が動き、何が見えてきたのか。株式会社ヤマサキのプロジェクトリーダー 田中敏彦氏と、CHAOSRU代表取締役の内藤薫氏に話を伺った。